Other official information and services: www.belgium.be  belgium

Antimigraine preparation

Key figures

PRESCRIBERS
Main prescribers: Neurology 56.10%
INSURED CONSUMERS
% of insured consumers 0.34%
Median age 45 years
Max/min ratio of the median age (by district) 1.14
Percentage of women 81.90%
Ratio Preferential scheme/General scheme 1.07
Coefficient of variation (2023) 30.11
Max/min ratio of % of insured consumers (by district) 2.91
CONSUMPTION
Annual consumption (DDD) 6,512,864
Consumption of DDD (per 100,000 insured persons) 56,532.80
% DDD issued outside the insurance (approximate) 45.88%
Average annual consumption per insured consumer (DDD) 164.72
% of insured consumers with > 3 times the average consumption 9,81%
Coefficient of variation 2013-2015 26.52
Coefficient of variation 2021-2023 31.13
Trend 2013-2023 28.71%
Trend 2013-2021 25.40%
Trend 2021-2023 42.83%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance 49,047,665 €
Average annual expenditure per insured person 4.26 €
Average patient share per insured consumer 3.42%
Max/min ratio of expenditure per insured person (by disctrict) 3.62
% “Low-cost” medication 38.20%
Trend 2013-2023 41.90%
Trend 2021-2023 89.43%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on a yellow background, otherwise on a grey background.

Download the full report

Download the methodology